The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Candidate mechanisms for chemotherapy-induced cognitive changes
Ahles, T. A., & Saykin, A. J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2073 · Cited by 916
Self-citationvan Dam, F. S. A. M., Boogerd, W., Schagen, S. B., Muller, M. J., Droogleever Fortuyn, M. E., Wall, E. V. D., & Rodenhuis, S. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.3.210 · Cited by 763
Self-citationAhles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., Whedon, M. B., Bivens, S., Mitchell, T., Greenberg, E. R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.485 · Cited by 736
Self-citationWefel, J. S., Lenzi, R., Theriault, R. L., Davis, R. N., & Meyers, C. A. (2004) · Cancer · doi:10.1002/cncr.20272 · Cited by 679
Self-citationThe HNRC 500-Neuropsychology of Hiv infection at different disease stages
Heaton, R. K., Grant, I., Butters, N., White, D. A., Kirson, D., Atkinson, J. H., McCutchan, J. A., Taylor, M. J., Kelly, M. D., Ellis, R. J., et al. (1995) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617700000230 · Cited by 631
Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma
Schagen, S. B., van Dam, F. S. A. M., Muller, M. J., Boogerd, W., Lindeboom, J., & Bruning, P. F. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990201)85:3<640::aid-cncr14>3.0.co;2-g · Cited by 620
Self-citationCognitive Function in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Brezden, C. B., Phillips, K.-A., Abdolell, M., Bunston, T., & Tannock, I. F. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.14.2695 · Cited by 557
Self-citationCarey, C. L., Woods, S. P., Gonzalez, R., Conover, E., Marcotte, T. D., Grant, I., & Heaton, R. K. (2004) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390490510031 · Cited by 544
Dietrich, J., Han, R., Yang, Y., Mayer-Pröschel, M., & Noble, M. (2006) · Journal of Biology · doi:10.1186/jbiol50 · Cited by 500
Meyers, C. A., Albitar, M., & Estey, E. (2005) · Cancer · doi:10.1002/cncr.21234 · Cited by 459
Cognitive Impairment Associated With Chemotherapy for Cancer: Report of a Workshop
Tannock, I. F., Ahles, T. A., Ganz, P. A., & van Dam, F. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.094 · Cited by 453
Self-citationJenkins, V, Shilling, V, Deutsch, G., Bloomfield, D., Morris, R., Allan, S., Bishop, H., Hodson, N., Mitra, S., Sadler, G., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603029 · Cited by 407
Silverman, D. H. S., Dy, C. J., Castellon, S. A., Lai, J., Pio, B. S., Abraham, L., Waddell, K., Petersen, L., Phelps, M. E., & Ganz, P. A. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9380-z · Cited by 397
Tchen, N., Juffs, H. G., Downie, F. P., Yi, Q.-L., Hu, H., Chemerynsky, I., Clemons, M., Crump, M., Goss, P. E., Warr, D., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.119 · Cited by 380
Self-citationAhles, T. A., Saykin, A. J., Noll, W. W., Furstenberg, C. T., Guerin, S., Cole, B., & Mott, L. A. (2003) · Psycho-Oncology · doi:10.1002/pon.742 · Cited by 357
Self-citationInagaki, M., Yoshikawa, E., Matsuoka, Y., Sugawara, Y., Nakano, T., Akechi, T., Wada, N., Imoto, S., Murakami, K., Uchitomi, Y., et al. (2007) · Cancer · doi:10.1002/cncr.22368 · Cited by 350
‘Chemobrain’ in breast carcinoma?: A prologue
Wefel, J. S., Lenzi, R., Theriault, R., Buzdar, A. U., Cruickshank, S., & Meyers, C. A. (2004) · Cancer · doi:10.1002/cncr.20393 · Cited by 334
Self-citationCognitive impairment associated with adjuvant therapy in breast cancer
Bender, C. M., Sereika, S. M., Berga, S. L., Vogel, V. G., Brufsky, A. M., Paraska, K. K., & Ryan, C. M. (2006) · Psycho-Oncology · doi:10.1002/pon.964 · Cited by 320
Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer
Wieneke, M. H., & Dienst, E. R. (1995) · Psycho-Oncology · doi:10.1002/pon.2960040108 · Cited by 317
Falleti, M. G., Sanfilippo, A., Maruff, P., Weih, L., & Phillips, K.-A. (2005) · Brain and Cognition · doi:10.1016/j.bandc.2005.05.001 · Cited by 315
ANDERSON-HANLEY, C., SHERMAN, M. L., RIGGS, R., AGOCHA, V. B., & COMPAS, B. E. (2003) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617703970019 · Cited by 302
Achieving and Maintaining Cognitive Vitality With Aging
Fillit, H. M., Butler, R. N., O'Connell, A. W., Albert, M. S., Birren, J. E., Cotman, C. W., Greenough, W. T., Gold, P. E., Kramer, A. F., Kuller, L. H., et al. (2002) · Mayo Clinic Proceedings · doi:10.4065/77.7.681 · Cited by 300
Schagen, S. B., Muller, M. J., Boogerd, W., Mellenbergh, G. J., & van Dam, F. S. A. M. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj470 · Cited by 295
Self-citationFan, H. G. M., Houédé-Tchen, N., Yi, Q.-L., Chemerynsky, I., Downie, F. P., Sabate, K., & Tannock, I. F. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.6550 · Cited by 280
Self-citationFerguson, R. J., McDonald, B. C., Saykin, A. J., & Ahles, T. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.8639 · Cited by 272
Self-citationVardy, J., Rourke, S., & Tannock, I. F. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.1604 · Cited by 270
Self-citationHeaton, R. (2001) · Archives of Clinical Neuropsychology · doi:10.1016/s0887-6177(99)00062-1 · Cited by 252
SEIGERS, R., SCHAGEN, S., BEERLING, W., BOOGERD, W., VANTELLINGEN, O., VANDAM, F., KOOLHAAS, J., & BUWALDA, B. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.08.004 · Cited by 246
Self-citationJansen, C. E., Miaskowski, C., Dodd, M., Dowling, G., & Kramer, J. (2005) · Cancer · doi:10.1002/cncr.21469 · Cited by 242
Stewart, A., Bielajew, C., Collins, B., Parkinson, M., & Tomiak, E. (2006) · The Clinical Neuropsychologist · doi:10.1080/138540491005875 · Cited by 225
(2000) · CrossRef Listing of Deleted DOIs · doi:10.1016/s1084-3612(03)00055-8 · Cited by 194
The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice
WINOCUR, G., VARDY, J., BINNS, M., KERR, L., & TANNOCK, I. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.07.010 · Cited by 193
Self-citationTAYLOR, M. J., & HEATON, R. K. (2001) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617701777107 · Cited by 174 · cited 1×
“appropriate ethnicity; (iii) summary or ‘global’deficit scores [23] often are preferable to analyzing individual test scores or averaging scores on the neuropsychological battery, because impairments may occur on different patterns of tests for different people, (summary deficit scores focus on problems wherever they…”
Neurotoxicity secondary to antineoplastic drugs
Tuxen, M. K., & Hansen, S. W. (1994) · Cancer Treatment Reviews · doi:10.1016/0305-7372(94)90027-2 · Cited by 167
Capuron, L., Ravaud, A., & Dantzer, R. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200105000-00007 · Cited by 148 · cited 1×
“interferon) have been associated with a variety of symptoms, including cognitive deficits [50, 51].”
BackgroundAnticancer agents are potent neurotoxins in vitro and in vivo
Rzeski, W., Pruskil, S., Macke, A., Felderhoff‐Mueser, U., Reiher, A. K., Hoerster, F., Jansma, C., Jarosz, B., Stefovska, V. G., Bittigau, P., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20185 · Cited by 134
Scherwath, A., Mehnert, A., Schleimer, B., Schirmer, L., Fehlauer, F., Kreienberg, R., Metzner, B., Thiel, E., Zander, A. R., Schulz‐Kindermann, F., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdj108 · Cited by 111
Cognitive Dysfunction and Depression During Treatment With Interferon-Alpha and Chemotherapy
Scheibel, R. S., Valentine, A. D., O'Brien, S. M., & Meyers, C. A. (2004) · Journal of Neuropsychiatry · doi:10.1176/jnp.16.2.185 · Cited by 99
Cancer chemotherapy impairs contextual but not cue-specific fear memory
MacLeod, J. E., DeLeo, J. A., Hickey, W. F., Ahles, T. A., Saykin, A. J., & Bucci, D. J. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.04.003 · Cited by 97
Self-citationLee, G. D., Longo, D. L., Wang, Y., Rifkind, J. M., Abdul-Raman, L., Mamczarz, J., Duffy, K. B., Spangler, E. L., Taub, D. D., Mattson, M. P., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1286 · Cited by 95
Kreukels, B. P. C., Schagen, S. B., Ridderinkhof, K. R., Boogerd, W. J., Hamburger, H., & van Dam, F. S. A. M. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-7093-3 · Cited by 86
Self-citationAGE-RELATED NEURODEGENERATION AND OXIDATIVE STRESS
Joseph, J. A., Denisova, N., Fisher, D., Shukitt‐Hale, B., Bickford, P. C., Prior, R. L., & Cao, G. (1998) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70092-x · Cited by 84
13th Annual Meeting of the Organization for Human Brain Mapping (2007)
Chan, C., He, J., Yuen, K., Wong, A., & Lee, T. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.03.045 · Cited by 84
Reiriz, A. B., Reolon, G. K., Preissler, T., Rosado, J. O., Henriques, J. A. P., Roesler, R., & Schwartsmann, G. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0138 · Cited by 83
Stemmer, S. M., Stears, J. C., Burton, B. S., Jones, R. B., & Simon, J. H. (1994) · PubMed Central · Cited by 82
Kreukels, B. P. C., Schagen, S. B., Ridderinkhof, K. R., Boogerd, W. J., Hamburger, H., Müller, M. J., & van Dam, F. S. A. M. (2006) · Clinical Breast Cancer · doi:10.3816/cbc.2006.n.015 · Cited by 82
Self-citationNo adverse effects of adjuvant chemotherapy on hippocampal volumein Japanese breast cancer survivors
Yoshikawa, E., Matsuoka, Y., Inagaki, M., Nakano, T., Akechi, T., Kobayakawa, M., Fujimori, M., Nakaya, N., Akizuki, N., Imoto, S., et al. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-1412-6 · Cited by 72
A pilot study of Interpersonal Psychotherapy by telephone with cancer patients and their partners
Donnelly, J. M., Kornblith, A. B., Fleishman, S., Zuckerman, E., Raptis, G., Hudis, C. A., Hamilton, N., Payne, D., Massie, M. J., Norton, L., et al. (2000) · Psycho-Oncology · doi:10.1002/(sici)1099-1611(200001/02)9:1 · Cited by 65
Barton, D. L., & Loprinzi, C. L. (2002) · Clinical Breast Cancer · doi:10.3816/cbc.2002.s.023 · Cited by 57
Vardy, J. L., Booth, C. M., Pond, G. R., Zhang, H. A., Galica, J., Dhillon, H. M., Clarke, S. J., & Tannock, I. F. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.9070 · Cited by 27
Self-citation
Cited by
Wefel, J. S., Vardy, J., Ahles, T., & Schagen, S. B. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70294-1 · Cited by 998
Self-citationCancer- and Cancer Treatment–Associated Cognitive Change: An Update on the State of the Science
Ahles, T. A., Root, J. C., & Ryan, E. L. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.0116 · Cited by 704
Self-citationKoppelmans, V., Breteler, M. M. B., Boogerd, W., Seynaeve, C., Gundy, C., & Schagen, S. B. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.0189 · Cited by 556
Self-citationAhles, T. A., Saykin, A. J., McDonald, B. C., Li, Y., Furstenberg, C. T., Hanscom, B. S., Mulrooney, T. J., Schwartz, G. N., & Kaufman, P. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0827 · Cited by 535
Self-citationOxidative Stress and Neurodegenerative Disorders
Li, J., O, W., Li, W., Jiang, Z.-G., & Ghanbari, H. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141224438 · Cited by 504
Metadata
- Authors
- Vardy, J., Wefel, J. S., Ahles, T., Tannock, I. F., & Schagen, S. B.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2008-04
- Volume
- 19
- Issue
- 4
- Pages
- 623-629
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2146778300
- Cited by
- 331
- References
- 50
- FWCI
- 16.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.